US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

60 degrees pharmaceuticals, Inc.

1.34

-0.0400-2.90%

Volume:144.91K

Turnover:195.33K

Market Cap:4.32M

PE:-0.09

High:1.40

Open:1.38

Low:1.32

Close:1.38

Loading ...

Overview Company News Filings

60 Degrees Pharmaceuticals Secures $5M in Recent Offering

60 Degrees Pharmaceuticals Announces $5 Million Public Offering with Potential Additional $5 Million from Warrant Exercises

60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine Against Lyme and Bartonella Bacteria

Press Release: 60 Degrees Pharmaceuticals Announces Closing of up to $10 Million Public Offering

60 Degrees Pharmaceuticals prices 2.6M shares at $1.90 in public offering

60 Degrees determines max commercial market size for ARAKODA at $245M annually

60 Degrees Pharmaceuticals to submit tafenoquine MUMS designation request to FDA

60 Degrees Pharmaceuticals to Submit MUMS (Minor Use/Minor Species) Designation Request to FDA for Tafenoquine for Acute Canine Babesiosis in 2025

60 Degrees Pharmaceuticals to sell 2.04M shares of common stock for holders

Director Cheryl Xu Reports Acquisition of Common Shares in 60 Degrees Pharmaceuticals Inc

60 Degrees announces results from an insurance claims analysis on babesiosis

60 Degrees Pharm Is Maintained at Buy by Ascendiant Capital

Press Release: 60 Degrees Pharmaceuticals Announces First Quarter 2025 Results

60 Degrees Q1 EPS $(1.56) Misses $(1.31) Estimate, Sales $183.01K Miss $227.00K Estimate

60 Degrees announces findings from online survey about babesiosis disease

Babesiosis Disease Burden in United States is Substantially Higher Than Official Estimates, According to Preliminary Results of 60 Degrees Pharma Survey

BRIEF-Geoff Dow to discuss Babesiosis at Healing Lyme Summit

Why 60 Degrees Pharmaceuticals, Inc. (SXTP) Went Down On Thursday?

Geoff Dow, PhD, Infectious Disease Product Development Expert, to Discuss Babesiosis at Healing Lyme Summit, April 15-21

Top Midday Gainers

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SXTP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SXTP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SXTP\",,,,,undefined,":{"symbol":"SXTP","market":"US","secType":"STK","nameCN":"60 degrees pharmaceuticals, Inc.","latestPrice":1.34,"timestamp":1753992000000,"preClose":1.38,"halted":0,"volume":144913,"delay":0,"floatShares":2849900,"shares":3226200,"eps":-14.643807,"marketStatus":"Pre-Mkt","change":-0.04,"latestTime":"08-01 07:37:24 EDT","open":1.38,"high":1.4035,"low":1.32,"amount":195334.2610808,"amplitude":0.060507,"askPrice":1.42,"askSize":50,"bidPrice":1.21,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-14.643807,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1754055000000},"marketStatusCode":1,"adr":0,"listingDate":1686801600000,"exchange":"NASDAQ","adjPreClose":1.34,"postHourTrading":{"tag":"盘后","latestPrice":1.31,"preClose":1.34,"latestTime":"19:40 EDT","volume":1706,"amount":2249.2395,"timestamp":1754005227847},"volumeRatio":0.8652953946161537},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SXTP\",,,,,undefined,":{"symbol":"SXTP","floatShares":2849900,"roa":"-89.53%","roe":"-183.98%","lyrEps":-18.545406,"volumeRatio":0.8652953946161537,"shares":3226200,"dividePrice":0,"high":1.4035,"amplitude":0.060507,"preClose":1.38,"low":1.32,"week52Low":1.26,"pbRate":"-0.79","psRate":"5.39","week52High":12.7,"institutionHeld":0,"latestPrice":1.34,"committee":0.333333,"eps":-14.643807,"divideRate":0,"volume":144913,"delay":0,"ttmEps":-14.643807,"open":1.38,"prevYearClose":6.45,"prevWeekClose":1.31,"prevMonthClose":1.34,"prevQuarterClose":2.37,"fiveDayClose":1.34,"twentyDayClose":2.46,"sixtyDayClose":2.37},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SXTP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2552549070","title":"60 Degrees Pharmaceuticals Secures $5M in Recent Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2552549070","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552549070?lang=en_us&edition=fundamental","pubTime":"2025-07-19 05:17","pubTimestamp":1752873479,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals, Inc. ( ($SXTP) ) has provided an announcement. On July 15, 2025, 60 Degrees Pharmaceuticals, Inc. announced a Securitie...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/60-degrees-pharmaceuticals-secures-5m-in-recent-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/60-degrees-pharmaceuticals-secures-5m-in-recent-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2552449096","title":"60 Degrees Pharmaceuticals Announces $5 Million Public Offering with Potential Additional $5 Million from Warrant Exercises","url":"https://stock-news.laohu8.com/highlight/detail?id=2552449096","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552449096?lang=en_us&edition=fundamental","pubTime":"2025-07-19 04:58","pubTimestamp":1752872309,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals Inc., a company focused on developing new medicines for infectious diseases, has announced the pricing of a public offering involving 2,631,578 shares of its common stock. This offering includes accompanying Series A-1 warrants and short-term Series A-2 warrants to purchase an equal number of shares, priced at $1.90 per share of common stock. The company anticipates gross proceeds of approximately $5 million from the offering, with the possibility of an additional $5 million if the short-term Series A-2 warrants are fully exercised on a cash basis. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering. The proceeds are intended for working capital and general corporate purposes.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250718:nNDL1wyyX8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2552489961","title":"60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine Against Lyme and Bartonella Bacteria","url":"https://stock-news.laohu8.com/highlight/detail?id=2552489961","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552489961?lang=en_us&edition=fundamental","pubTime":"2025-07-17 20:01","pubTimestamp":1752753660,"startTime":"0","endTime":"0","summary":"Study will evaluate activity of tafenoquine against vector-borne pathogens, Borrelia (Lyme disease) and Bartonella in cell cultureBorrelia and Bartonella, together with Babesia, represent the \"3Bs,\" p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/17/3117175/0/en/60-Degrees-Pharmaceuticals-and-Tulane-University-Sign-Research-Agreement-to-Study-Tafenoquine-Against-Lyme-and-Bartonella-Bacteria.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALT","BK4139","LU1878469433.USD","SXTP","BK4599"],"gpt_icon":0},{"id":"2552786831","title":"Press Release: 60 Degrees Pharmaceuticals Announces Closing of up to $10 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2552786831","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552786831?lang=en_us&edition=fundamental","pubTime":"2025-07-17 04:01","pubTimestamp":1752696060,"startTime":"0","endTime":"0","summary":"WASHINGTON, July 16, 2025  -- 60 Degrees Pharmaceuticals, Inc.  , a pharmaceutical company focused on developing new medicines for infectious diseases, today announced the closing of its previously announced public offering of 2,631,578 shares of the Company's common stock  and accompanying Series A-1 warrants to purchase up to 2,631,578 shares of common stock and short-term Series A-2 warrants to purchase up to 2,631,578 shares of common stock, at a combined offering price of $1.90 per share of common stock  and accompanying warrants.The Series A-1 warrants have an exercise price of $1.90 per share, are exercisable upon issuance and expire five years thereafter. The short-term Series A-2 warrants have an exercise price of $1.90 per share, are exercisable upon issuance and expire 18 months thereafter.60 Degrees Pharmaceuticals, Inc., founded in 2010, specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases that affect the lives of mi","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4022","BK4007","BK4232","R"],"gpt_icon":0},{"id":"2551603701","title":"60 Degrees Pharmaceuticals prices 2.6M shares at $1.90 in public offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2551603701","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551603701?lang=en_us&edition=fundamental","pubTime":"2025-07-15 21:20","pubTimestamp":1752585632,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals (SXTP) announced the pricing of a public offering of 2,631,578 shares of the Company’s common stock and accompanying Ser...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/60-degrees-pharmaceuticals-prices-2-6m-shares-at-1-90-in-public-offering-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/60-degrees-pharmaceuticals-prices-2-6m-shares-at-1-90-in-public-offering-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2551016126","title":"60 Degrees determines max commercial market size for ARAKODA at $245M annually","url":"https://stock-news.laohu8.com/highlight/detail?id=2551016126","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551016126?lang=en_us&edition=fundamental","pubTime":"2025-07-15 19:15","pubTimestamp":1752578137,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals (SXTP) announced it has determined the maximum size of the commercial market for ARAKODA for treatment of human babesios...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/60-degrees-determines-max-commercial-market-size-for-arakoda-at-245m-annually-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/60-degrees-determines-max-commercial-market-size-for-arakoda-at-245m-annually-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2551135748","title":"60 Degrees Pharmaceuticals to submit tafenoquine MUMS designation request to FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2551135748","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551135748?lang=en_us&edition=fundamental","pubTime":"2025-07-15 04:10","pubTimestamp":1752523815,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals (SXTP) announced that the company will conduct a gap analysis of its existing data prior to submitting a minor use minor...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/60-degrees-pharmaceuticals-to-submit-tafenoquine-mums-designation-request-to-fda-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/60-degrees-pharmaceuticals-to-submit-tafenoquine-mums-designation-request-to-fda-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2551135953","title":"60 Degrees Pharmaceuticals to Submit MUMS (Minor Use/Minor Species) Designation Request to FDA for Tafenoquine for Acute Canine Babesiosis in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2551135953","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551135953?lang=en_us&edition=fundamental","pubTime":"2025-07-15 04:01","pubTimestamp":1752523260,"startTime":"0","endTime":"0","summary":"Data from three independent clinical studies demonstrate utility of tafenoquine to treat acute canine babesiosis WASHINGTON, July  14, 2025  (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc.(NASDAQ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/14/3115142/0/en/60-Degrees-Pharmaceuticals-to-Submit-MUMS-Minor-Use-Minor-Species-Designation-Request-to-FDA-for-Tafenoquine-for-Acute-Canine-Babesiosis-in-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMC","BK4139","LU1878469433.USD","LU0971096721.USD","IE00B1BXHZ80.USD","LU0882574139.USD","BK4007","BK4006","LU0149725797.USD","LU0170899867.USD","LU0267386448.USD","BK4599","IE00BKVL7J92.USD","IE00BHPRN162.USD","SXTP","ALT","LU1363072403.SGD","IE00BZ1G4Q59.USD"],"gpt_icon":0},{"id":"2549649563","title":"60 Degrees Pharmaceuticals to sell 2.04M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2549649563","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549649563?lang=en_us&edition=fundamental","pubTime":"2025-07-08 05:55","pubTimestamp":1751925309,"startTime":"0","endTime":"0","summary":"17:52 EDT 60 Degrees Pharmaceuticals (SXTP) to sell 2.04M shares of common stock for holders Published first on TheFly – the ultimate source for re...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/60-degrees-pharmaceuticals-to-sell-2-04m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/60-degrees-pharmaceuticals-to-sell-2-04m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2541100724","title":"Director Cheryl Xu Reports Acquisition of Common Shares in 60 Degrees Pharmaceuticals Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2541100724","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541100724?lang=en_us&edition=fundamental","pubTime":"2025-06-06 08:53","pubTimestamp":1749171217,"startTime":"0","endTime":"0","summary":"Cheryl Xu, a Director at 60 Degrees Pharmaceuticals Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 60 Degrees Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nNDL9gm9R9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director Cheryl Xu Reports Acquisition of Common Shares in 60 Degrees Pharmaceuticals Inc","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2540743067","title":"60 Degrees announces results from an insurance claims analysis on babesiosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2540743067","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540743067?lang=en_us&edition=fundamental","pubTime":"2025-06-03 20:55","pubTimestamp":1748955329,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals (SXTP) announced results of an insurance claims analysis related to babesiosis and chronic fatigue, as conducted by Komo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/60-degrees-announces-results-from-an-insurance-claims-analysis-on-babesiosis-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/60-degrees-announces-results-from-an-insurance-claims-analysis-on-babesiosis-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2540769761","title":"60 Degrees Pharm Is Maintained at Buy by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2540769761","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540769761?lang=en_us&edition=fundamental","pubTime":"2025-06-02 17:52","pubTimestamp":1748857920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SXTP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 02, 2025 05:52 ET (09:52 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP"],"gpt_icon":0},{"id":"2535808189","title":"Press Release: 60 Degrees Pharmaceuticals Announces First Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2535808189","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535808189?lang=en_us&edition=fundamental","pubTime":"2025-05-16 04:31","pubTimestamp":1747341060,"startTime":"0","endTime":"0","summary":"-- Q1 2024 net product revenues increased 55% year-over-year to $163.6. -- Gross profit increased 124% to $90.3 thousand.WASHINGTON, May 15, 2025  -- 60 Degrees Pharmaceuticals, Inc.  , a pharmaceutical company focused on developing new medicines for infectious diseases, reported today their financial results for the first fiscal quarter of the 2025 year, ended March 31, 2025.-- Net product revenues increased approximately 55% from $105.7 thousand for. the first quarter of 2024 to approximately $163.6 thousand for the first. quarter of 2025; the Company credits growth from domestic sales of. -- The Company achieved a gross profit of approximately $90.3 thousand in. the first quarter of 2025, compared with an approximate gross profit. of $40.2 thousand in the first quarter of 2024.-- Operating expenses were approximately $2.09 million in the first quarter. of 2025, compared with approximately $1.41 million in the first quarter. of 2024. Increased expenditures in sales and investor-relat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4022","SXTP","BK4232","BK4007"],"gpt_icon":0},{"id":"2535824808","title":"60 Degrees Q1 EPS $(1.56) Misses $(1.31) Estimate, Sales $183.01K Miss $227.00K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535824808","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535824808?lang=en_us&edition=fundamental","pubTime":"2025-05-15 22:23","pubTimestamp":1747319004,"startTime":"0","endTime":"0","summary":"60 Degrees (NASDAQ:SXTP) reported quarterly losses of $(1.56) per share which missed the analyst consensus estimate of $(1.31) by 19.08 percent. This is a 185.25 percent decrease over earnings of $1.83 per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45440351/60-degrees-q1-eps-1-56-misses-1-31-estimate-sales-183-01k-miss-227-00k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP"],"gpt_icon":0},{"id":"2529307332","title":"60 Degrees announces findings from online survey about babesiosis disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2529307332","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529307332?lang=en_us&edition=fundamental","pubTime":"2025-04-22 20:50","pubTimestamp":1745326255,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals (SXTP)announced findings that the actual burden of babesiosis in the United States may be significantly higher than Cent...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/60-degrees-announces-findings-from-online-survey-about-babesiosis-disease?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/60-degrees-announces-findings-from-online-survey-about-babesiosis-disease?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2529307763","title":"Babesiosis Disease Burden in United States is Substantially Higher Than Official Estimates, According to Preliminary Results of 60 Degrees Pharma Survey","url":"https://stock-news.laohu8.com/highlight/detail?id=2529307763","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529307763?lang=en_us&edition=fundamental","pubTime":"2025-04-22 20:44","pubTimestamp":1745325840,"startTime":"0","endTime":"0","summary":"In a survey representative of the general U.S. adult population, 1.26 percent of respondents – equivalent to about 3 million people – reported having received a medical diagnosis of babesiosis during their life-time; CDC data imply only about 73,000 people in that category.At the time they replied to the survey, 3.7 percent of respondents – equivalent to about 9.9 million people – reported they had been experiencing fatigue, a common symptom of babesiosis, for six months or longer.The online quantitative survey was conducted among a general adult population sample of 6,000 adults, with demographic variables  matched to U.S. census data for optimal representation of the U.S. population. Babesiosis was reported as a diagnosed medical condition experienced by 1.26 percent of respondents, implying that 3 million Americans may have experienced babesiosis . Moreover, approximately 17 percent of babesiosis patien","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/babesiosis-disease-burden-united-states-124400994.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4211","SXTP","SXTPW","BK4007","CDC","UBCP"],"gpt_icon":0},{"id":"2526598000","title":"BRIEF-Geoff Dow to discuss Babesiosis at Healing Lyme Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2526598000","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526598000?lang=en_us&edition=fundamental","pubTime":"2025-04-10 22:03","pubTimestamp":1744293838,"startTime":"0","endTime":"0","summary":"BRIEF-Geoff Dow to discuss Babesiosis at Healing Lyme SummitApril 10 (Reuters) - Dow Inc DOW.N:GEOFF DOW, PHD, INFECTIOUS DISEASE PRODUCT DEVELOPMENT EXPERT, TO DISCUSS BABESIOSIS AT HEALING LYME SUMM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nTUABGJDPD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DOW","BK4007","BK4090","BK4585","SXTP","BK4588","SXTPW"],"gpt_icon":0},{"id":"2526956033","title":"Why 60 Degrees Pharmaceuticals, Inc. (SXTP) Went Down On Thursday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2526956033","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526956033?lang=en_us&edition=fundamental","pubTime":"2025-04-10 21:24","pubTimestamp":1744291448,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Stocks Fall Behind Amid Market Optimism. In this article, we are going to take a look at where 60 Degrees Pharmaceuticals, Inc.  stands against other stocks that fall behind amid market optimism.Wall Street’s main indices rebounded from hefty losses on Wednesday after President Donald Trump announced that the US will pause the imposition of higher tariffs on 75 countries for 90 days.In a post on Truth Social, Trump said that more than 75 countries have called to negotiate and have not retaliated in any way.“I have authorized a 90-day PAUSE, and a substantially lowered Reciprocal Tariff during this period, of 10%, also effective immediately,” he noted.Following the announcement, the Dow Jones jumped by 7.87 percent, the S&P 500 surged by 9.52 percent, and the tech-heavy Nasdaq soared by 12.16 percent.Despite the overall market optimism, 10 companies, predominantly in the biopharmaceutical sector, registered losses amid the lack of fresh developments to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-60-degrees-pharmaceuticals-inc-132408554.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SXTPW","SXTP","BK4007"],"gpt_icon":0},{"id":"2526566242","title":"Geoff Dow, PhD, Infectious Disease Product Development Expert, to Discuss Babesiosis at Healing Lyme Summit, April 15-21","url":"https://stock-news.laohu8.com/highlight/detail?id=2526566242","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526566242?lang=en_us&edition=fundamental","pubTime":"2025-04-10 20:31","pubTimestamp":1744288260,"startTime":"0","endTime":"0","summary":"WASHINGTON, April  10, 2025  (GLOBE NEWSWIRE) -- Geoff Dow, infectious disease product development expert and chief executive officer of 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Deg","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/10/3059256/0/en/Geoff-Dow-PhD-Infectious-Disease-Product-Development-Expert-to-Discuss-Babesiosis-at-Healing-Lyme-Summit-April-15-21.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMMF","BK4211","BK4007","SXTP"],"gpt_icon":0},{"id":"2526841906","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2526841906","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526841906?lang=en_us&edition=fundamental","pubTime":"2025-04-09 02:21","pubTimestamp":1744136475,"startTime":"0","endTime":"0","summary":"FatPipe  shares surged over 200% in their trading debut on Nasdaq Tuesday after the company priced its initial public offering of 695,656 shares at $5.75 apiece to raise about $4 million.60 Degrees Pharmaceuticals  said it signed a patent license deal with Yale School of Medicine and Yale School of Public Health to jointly develop and commercialize Tafenoquine for the treatment and prevention of tick-borne disease babesiosis.Shares surged 64%, with intraday trading volume catapulted to over 73.8 million from a daily average of about 419,000.Price: 18.25, Change: +12.50, Percent Change: +217.30","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FATN","BK4007","SXTP"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":37,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SXTP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-24","symbol":"SXTP","defaultRemindTime":1740407400000,"type":"split","dateTimestamp":1740373200000,"forFactor":5,"toFactor":1,"ratio":5},{"market":"US","date":"2024-08-12","symbol":"SXTP","defaultRemindTime":1723469400000,"type":"split","dateTimestamp":1723435200000,"forFactor":12,"toFactor":1,"ratio":12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SXTP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SXTP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1697860800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SXTP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SXTP","date":"2025-07-31","current":-0.434182,"percent":0.695122,"low":-5.827686,"twenty":-1.50777,"median":-0.798882,"eighty":-0.371982,"high":-0.148542,"avg":-1.101114,"sd":1.096123,"marketCap":4452162},"quantilePoints":[{"date":"2023-07-14","current":-3.206044,"twenty":-3.575483,"median":-3.312205,"eighty":-3.248508,"marketCap":25229961},{"date":"2023-07-21","current":-2.066589,"twenty":-3.269741,"median":-2.519541,"eighty":-2.109053,"marketCap":16263021},{"date":"2023-07-28","current":-1.549942,"twenty":-3.005047,"median":-2.066589,"eighty":-1.612223,"marketCap":12197266},{"date":"2023-08-04","current":-1.436704,"twenty":-2.556343,"median":-1.68795,"eighty":-1.51314,"marketCap":11306141},{"date":"2023-08-11","current":-1.082836,"twenty":-2.270417,"median":-1.578251,"eighty":-1.364515,"marketCap":8521377},{"date":"2023-08-18","current":-1.132378,"twenty":-2.130285,"median":-1.514555,"eighty":-1.186166,"marketCap":8911244},{"date":"2023-08-25","current":-1.075759,"twenty":-1.995815,"median":-1.493323,"eighty":-1.119638,"marketCap":8465682},{"date":"2023-09-01","current":-0.896195,"twenty":-1.818881,"median":-1.298696,"eighty":-1.075759,"marketCap":8118769},{"date":"2023-09-08","current":-0.774624,"twenty":-1.702813,"median":-1.231461,"eighty":-0.96014,"marketCap":7017437},{"date":"2023-09-15","current":-0.729811,"twenty":-1.64761,"median":-1.146532,"eighty":-0.891125,"marketCap":6611469},{"date":"2023-09-22","current":-0.512148,"twenty":-1.583913,"median":-1.121762,"eighty":-0.799591,"marketCap":4639628},{"date":"2023-09-29","current":-0.473737,"twenty":-1.572589,"median":-1.082836,"eighty":-0.74506,"marketCap":4291655},{"date":"2023-10-06","current":-0.428924,"twenty":-1.54428,"median":-1.043911,"eighty":-0.582824,"marketCap":3885688},{"date":"2023-10-13","current":-0.449858,"twenty":-1.518801,"median":-0.952467,"eighty":-0.507026,"marketCap":4075333},{"date":"2023-10-20","current":-0.524952,"twenty":-1.507478,"median":-0.898787,"eighty":-0.48823,"marketCap":4755618},{"date":"2023-10-27","current":-0.423162,"twenty":-1.507478,"median":-0.893026,"eighty":-0.483288,"marketCap":3833492},{"date":"2023-11-03","current":-0.377709,"twenty":-1.498985,"median":-0.86425,"eighty":-0.474121,"marketCap":3421725},{"date":"2023-11-10","current":-0.384111,"twenty":-1.459352,"median":-0.781026,"eighty":-0.464774,"marketCap":3479721},{"date":"2023-11-17","current":-0.435326,"twenty":-1.364515,"median":-0.768158,"eighty":-0.451894,"marketCap":3943683},{"date":"2023-11-24","current":-0.957437,"twenty":-1.302234,"median":-0.768222,"eighty":-0.451215,"marketCap":3282536},{"date":"2023-12-01","current":-1.048783,"twenty":-1.272509,"median":-0.817837,"eighty":-0.455018,"marketCap":3595711},{"date":"2023-12-08","current":-1.126596,"twenty":-1.237122,"median":-0.883455,"eighty":-0.458974,"marketCap":3862490},{"date":"2023-12-15","current":-1.209483,"twenty":-1.239655,"median":-0.898787,"eighty":-0.463494,"marketCap":4146667},{"date":"2023-12-22","current":-1.860743,"twenty":-1.313345,"median":-0.952467,"eighty":-0.469896,"marketCap":6379488},{"date":"2023-12-29","current":-1.877659,"twenty":-1.436704,"median":-0.957437,"eighty":-0.473737,"marketCap":6437483},{"date":"2024-01-05","current":-1.843828,"twenty":-1.498985,"median":-0.99083,"eighty":-0.473737,"marketCap":6321493},{"date":"2024-01-12","current":-1.684903,"twenty":-1.535158,"median":-1.005049,"eighty":-0.473737,"marketCap":5776626},{"date":"2024-01-19","current":-1.239932,"twenty":-1.578554,"median":-1.044215,"eighty":-0.473993,"marketCap":4251059},{"date":"2024-01-26","current":-0.829046,"twenty":-1.566927,"median":-1.048783,"eighty":-0.474761,"marketCap":2842352},{"date":"2024-02-02","current":-0.925149,"twenty":-1.540086,"median":-1.013507,"eighty":-0.475465,"marketCap":3171838},{"date":"2024-02-09","current":-0.910618,"twenty":-1.523834,"median":-0.998035,"eighty":-0.47745,"marketCap":3122019},{"date":"2024-02-16","current":-1.032034,"twenty":-1.51597,"median":-0.998035,"eighty":-0.482239,"marketCap":3538288},{"date":"2024-02-23","current":-0.952597,"twenty":-1.507478,"median":-0.999534,"eighty":-0.485478,"marketCap":3265942},{"date":"2024-03-01","current":-0.872837,"twenty":-1.504647,"median":-0.997482,"eighty":-0.487014,"marketCap":2992488},{"date":"2024-03-08","current":-0.96067,"twenty":-1.485273,"median":-0.987859,"eighty":-0.492942,"marketCap":3293619},{"date":"2024-03-15","current":-0.79114,"twenty":-1.449798,"median":-0.959539,"eighty":-0.498115,"marketCap":2712392},{"date":"2024-03-22","current":-0.916107,"twenty":-1.420017,"median":-0.955017,"eighty":-0.500624,"marketCap":3140839},{"date":"2024-03-28","current":-0.855077,"twenty":-1.353268,"median":-0.952532,"eighty":-0.505746,"marketCap":2931598},{"date":"2024-04-05","current":-0.849647,"twenty":-1.338044,"median":-0.936451,"eighty":-0.512148,"marketCap":3199516},{"date":"2024-04-12","current":-0.816395,"twenty":-1.316389,"median":-0.933222,"eighty":-0.524952,"marketCap":3074302},{"date":"2024-04-19","current":-0.757247,"twenty":-1.308779,"median":-0.92967,"eighty":-0.530713,"marketCap":2851568},{"date":"2024-04-26","current":-0.717764,"twenty":-1.281002,"median":-0.922727,"eighty":-0.537755,"marketCap":2702887},{"date":"2024-05-03","current":-0.712848,"twenty":-1.27038,"median":-0.915462,"eighty":-0.550879,"marketCap":2684374},{"date":"2024-05-10","current":-0.706703,"twenty":-1.25977,"median":-0.903415,"eighty":-0.619133,"marketCap":2661232},{"date":"2024-05-17","current":-3.509711,"twenty":-1.27038,"median":-0.90138,"eighty":-0.641256,"marketCap":2580238},{"date":"2024-05-24","current":-4.594449,"twenty":-1.338044,"median":-0.91304,"eighty":-0.64525,"marketCap":3377706},{"date":"2024-05-31","current":-4.661966,"twenty":-1.461121,"median":-0.918206,"eighty":-0.666636,"marketCap":3427342},{"date":"2024-06-07","current":-5.728069,"twenty":-1.522366,"median":-0.927087,"eighty":-0.675178,"marketCap":4211110},{"date":"2024-06-14","current":-4.678752,"twenty":-1.578453,"median":-0.931607,"eighty":-0.675977,"marketCap":3439683},{"date":"2024-06-21","current":-4.565851,"twenty":-1.664999,"median":-0.933222,"eighty":-0.682122,"marketCap":3356681},{"date":"2024-06-28","current":-4.459591,"twenty":-1.683685,"median":-0.93467,"eighty":-0.688267,"marketCap":3278562},{"date":"2024-07-05","current":-3.848597,"twenty":-1.749099,"median":-0.942586,"eighty":-0.700189,"marketCap":2829377},{"date":"2024-07-12","current":-4.084361,"twenty":-1.843828,"median":-0.952597,"eighty":-0.706457,"marketCap":3002704},{"date":"2024-07-15","current":-4.07606,"twenty":-1.847211,"median":-0.952597,"eighty":-0.70658,"marketCap":2996601},{"date":"2024-08-02","current":-2.282925,"twenty":-1.860743,"median":-0.955017,"eighty":-0.706703,"marketCap":1678340},{"date":"2024-08-09","current":-1.534126,"twenty":-1.877659,"median":-0.959539,"eighty":-0.710605,"marketCap":1127845},{"date":"2024-08-16","current":-1.068072,"twenty":-1.877659,"median":-0.987859,"eighty":-0.712848,"marketCap":1678338},{"date":"2024-08-23","current":-2.160665,"twenty":-1.877659,"median":-0.997482,"eighty":-0.717764,"marketCap":3395207},{"date":"2024-08-30","current":-1.710527,"twenty":-1.890582,"median":-0.999534,"eighty":-0.729811,"marketCap":2687872},{"date":"2024-09-06","current":-1.620499,"twenty":-1.88984,"median":-1.0072,"eighty":-0.729811,"marketCap":2546405},{"date":"2024-09-13","current":-1.530471,"twenty":-1.880058,"median":-1.014951,"eighty":-0.730006,"marketCap":2404938},{"date":"2024-09-20","current":-1.521468,"twenty":-1.877659,"median":-1.04133,"eighty":-0.731038,"marketCap":2390791},{"date":"2024-09-27","current":-1.468799,"twenty":-1.869809,"median":-1.049471,"eighty":-0.737686,"marketCap":2308028},{"date":"2024-10-04","current":-1.255991,"twenty":-1.862164,"median":-1.066844,"eighty":-0.740259,"marketCap":1973628},{"date":"2024-10-11","current":-1.244142,"twenty":-1.847211,"median":-1.075002,"eighty":-0.740502,"marketCap":1955009},{"date":"2024-10-18","current":-1.232293,"twenty":-1.843828,"median":-1.079298,"eighty":-0.743697,"marketCap":1936390},{"date":"2024-10-25","current":-1.016642,"twenty":-1.840904,"median":-1.082836,"eighty":-0.754697,"marketCap":1597522},{"date":"2024-10-31","current":-0.975171,"twenty":-1.832216,"median":-1.075759,"eighty":-0.763051,"marketCap":1532355},{"date":"2024-11-08","current":-1.26784,"twenty":-1.806613,"median":-1.075381,"eighty":-0.767663,"marketCap":1992247},{"date":"2024-11-15","current":-1.125653,"twenty":-1.78406,"median":-1.082836,"eighty":-0.768196,"marketCap":1768818},{"date":"2024-11-22","current":-0.205615,"twenty":-1.766768,"median":-1.075381,"eighty":-0.742898,"marketCap":1627312},{"date":"2024-11-29","current":-0.307708,"twenty":-1.757765,"median":-1.071273,"eighty":-0.734485,"marketCap":2435312},{"date":"2024-12-06","current":-0.345446,"twenty":-1.750257,"median":-1.065617,"eighty":-0.722583,"marketCap":2733983},{"date":"2024-12-13","current":-0.47898,"twenty":-1.738613,"median":-1.055566,"eighty":-0.706334,"marketCap":3790817},{"date":"2024-12-20","current":-0.40931,"twenty":-1.727188,"median":-1.048783,"eighty":-0.67358,"marketCap":3239425},{"date":"2024-12-27","current":-0.38899,"twenty":-1.717281,"median":-1.039648,"eighty":-0.641313,"marketCap":3078603},{"date":"2025-01-03","current":-0.380281,"twenty":-1.712721,"median":-1.016642,"eighty":-0.550879,"marketCap":3009679},{"date":"2025-01-10","current":-0.316417,"twenty":-1.710966,"median":-1.012063,"eighty":-0.522391,"marketCap":2504236},{"date":"2025-01-17","current":-0.239606,"twenty":-1.690028,"median":-1.00281,"eighty":-0.496592,"marketCap":1896327},{"date":"2025-01-24","current":-0.255137,"twenty":-1.68399,"median":-0.998035,"eighty":-0.483288,"marketCap":2019241},{"date":"2025-01-31","current":-0.232233,"twenty":-1.673079,"median":-0.992315,"eighty":-0.474953,"marketCap":1837972},{"date":"2025-02-07","current":-0.153564,"twenty":-1.664392,"median":-0.980029,"eighty":-0.471176,"marketCap":1215358},{"date":"2025-02-14","current":-0.582606,"twenty":-1.637571,"median":-0.96067,"eighty":-0.473737,"marketCap":4610947},{"date":"2025-02-21","current":-0.439583,"twenty":-1.620499,"median":-0.957437,"eighty":-0.473737,"marketCap":3479015},{"date":"2025-02-28","current":-0.349879,"twenty":-1.606995,"median":-0.952597,"eighty":-0.455018,"marketCap":2769070},{"date":"2025-03-07","current":-0.295909,"twenty":-1.586175,"median":-0.942586,"eighty":-0.438837,"marketCap":2341926},{"date":"2025-03-14","current":-0.325686,"twenty":-1.5827,"median":-0.933946,"eighty":-0.428924,"marketCap":2577592},{"date":"2025-03-21","current":-0.36849,"twenty":-1.578554,"median":-0.931607,"eighty":-0.419612,"marketCap":2916361},{"date":"2025-03-28","current":-0.338713,"twenty":-1.572643,"median":-0.927312,"eighty":-0.40931,"marketCap":2680696},{"date":"2025-04-04","current":-0.34102,"twenty":-1.562151,"median":-0.925149,"eighty":-0.394645,"marketCap":2710119},{"date":"2025-04-11","current":-0.574544,"twenty":-1.556789,"median":-0.915785,"eighty":-0.39251,"marketCap":4565962},{"date":"2025-04-17","current":-0.587517,"twenty":-1.553338,"median":-0.908035,"eighty":-0.394595,"marketCap":4669064},{"date":"2025-04-25","current":-0.543037,"twenty":-1.552371,"median":-0.898993,"eighty":-0.395957,"marketCap":4315570},{"date":"2025-05-02","current":-0.459635,"twenty":-1.549767,"median":-0.893026,"eighty":-0.401762,"marketCap":3652769},{"date":"2025-05-09","current":-0.418861,"twenty":-1.547598,"median":-0.874888,"eighty":-0.406988,"marketCap":3328733},{"date":"2025-05-16","current":-0.398474,"twenty":-1.541724,"median":-0.870254,"eighty":-0.406988,"marketCap":3166715},{"date":"2025-05-23","current":-0.323906,"twenty":-1.541274,"median":-0.86425,"eighty":-0.394595,"marketCap":3321369},{"date":"2025-05-30","current":-0.382079,"twenty":-1.539474,"median":-0.855077,"eighty":-0.384111,"marketCap":3917890},{"date":"2025-06-06","current":-0.425171,"twenty":-1.534126,"median":-0.848946,"eighty":-0.384111,"marketCap":4359757},{"date":"2025-06-13","current":-0.327497,"twenty":-1.530471,"median":-0.844971,"eighty":-0.384111,"marketCap":3358191},{"date":"2025-06-20","current":-0.31026,"twenty":-1.530471,"median":-0.840362,"eighty":-0.383346,"marketCap":3181444},{"date":"2025-06-27","current":-0.350479,"twenty":-1.530471,"median":-0.828469,"eighty":-0.382076,"marketCap":3593854},{"date":"2025-07-03","current":-0.34186,"twenty":-1.52737,"median":-0.817007,"eighty":-0.376415,"marketCap":3505480},{"date":"2025-07-11","current":-0.374897,"twenty":-1.5231,"median":-0.815166,"eighty":-0.372679,"marketCap":3844245},{"date":"2025-07-18","current":-0.475084,"twenty":-1.521534,"median":-0.809921,"eighty":-0.369678,"marketCap":4871569},{"date":"2025-07-25","current":-0.421598,"twenty":-1.513366,"median":-0.799667,"eighty":-0.370493,"marketCap":4323114},{"date":"2025-07-31","current":-0.434182,"twenty":-1.50777,"median":-0.798882,"eighty":-0.371982,"marketCap":4452162}],"updateTime":1754048244411}}}